Matthew Jenusaitis's Insider Trades & SAST Disclosures

Matthew Jenusaitis's most recent trade in enVVeno Medical Corporation was a trade of 135,883 Stock Options done . Disclosure was reported to the exchange on Dec. 11, 2025.

Share

Note

This is a custom search result for pattern Matthew Jenusaitis.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
enVVeno Medical Corp Results Board Meeting High Loss High Volume	Matthew M. Jenusaitis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Dec 2025	135,883	135,883	-		-	Stock Options
enVVeno Medical Corp Results Board Meeting High Loss High Volume	Matthew Jenusaitis M.	Director	Purchase of securities on an exchange or from another person at price $ 2.53 per share.	19 Dec 2024	9,620	16,545 (0%)	0%	2.5	24,339	Common Stock
enVVeno Medical Corp Results Board Meeting High Loss High Volume	M. Jenusaitis Matthew	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Dec 2024	19,752	19,752	-		-	Stock Options
enVVeno Medical Corp Results Board Meeting High Loss High Volume	Matthew Jenusaitis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Dec 2023	13,856	13,856	-		-	Stock Options
enVVeno Medical Corp Results Board Meeting High Loss High Volume	Matthew Jenusaitis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Nov 2022	8,403	8,403	-		-	Stock Options
enVVeno Medical Corp Results Board Meeting High Loss High Volume	Matthew Jenusaitis	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Sep 2022	1,041	6,925 (0%)	0%		-	Common Stock
enVVeno Medical Corp Results Board Meeting High Loss High Volume	Matthew Jenusaitis	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Sep 2022	1,041	0	-		-	Restricted Stock Units
enVVeno Medical Corp Results Board Meeting High Loss High Volume	Matthew Jenusaitis	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Nov 2021	7,211	7,211	-		-	Stock Options
enVVeno Medical Corp Results Board Meeting High Loss High Volume	Matthew Jenusaitis	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Sep 2021	1,042	2,084	-		-	Restricted Stock Units
enVVeno Medical Corp Results Board Meeting High Loss High Volume	Matthew Jenusaitis	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 Sep 2021	1,042	5,884 (0%)	0%		-	Common Stock
enVVeno Medical Corp Results Board Meeting High Loss High Volume	Matthew Jenusaitis	Director	Purchase of securities on an exchange or from another person at price $ 7.70 per share.	25 Aug 2021	1,300	4,842 (0%)	0%	7.7	10,010	Common Stock, $$0.00001 par value

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades